Molecules, Vol. 24, Pages 794: Urinary Proteomics Profiles Are Useful for Detection of Cancer Biomarkers and Changes Induced by Therapeutic Procedures
In this study, urine samples were used to identify protein profiles prior and after drug infusion during surgery. Here, an approach that is based on the mass spectrometry (MS)-based proteomic analysis of urine samples from head and neck squamous cell carcinoma (HNSCC) and thyroid cancer patients is presented. This method allowed the identification of several inflammation- and cancer-related proteins, which could serve as tumor biomarkers. In addition, changes in the urinary proteome during and after therapeutic interventions were detected. In particular, a reduction of three proteins that were involved in inflammation has been observed: Galectin-3 Binding Protein, CD44, and osteopontin. The present work represents a proof of principle to follow proteasome changes during complex treatments based on urine samples.
Source: Molecules - Category: Chemistry Authors: Emanuele Ferrari Andrea Wittig Fabrizio Basilico Rossana Rossi Antonella De Palma Dario Di Silvestre Wolfgang Sauerwein Pier Mauri Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Head and Neck Cancer | HNSCC | Skin Cancer | Squamous Cell Carcinoma | Study | Thyroid | Thyroid Cancer